| A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain (NCT06741085) | Memorial Sloan Kettering Cancer Center | 2024-12-13 |
| A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors (NCT06710847) | GlaxoSmithKline | 2024-12-13 |
| Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) (NCT06394830) | Vaneltix Pharma, Inc. | 2024-12-13 |
| Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma (NCT06781567) | HitGen Inc. | 2024-12-13 |
| Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT06271616) | Mayo Clinic | 2024-12-13 |
| Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB) (NCT06829329) | Ausper Biopharma Co., Ltd. | 2024-12-13 |
| Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer (NCT06008730) | Emory University | 2024-12-13 |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer (NCT06201234) | GBG Forschungs GmbH | 2024-12-13 |
| A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (NCT06628310) | AbbVie | 2024-12-13 |
| First in Human Study of TUB-030 in Patients With Advanced Solid Tumors (NCT06657222) | Tubulis GmbH | 2024-12-13 |
| Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) (NCT06463457) | Atish Choudhury, MD | 2024-12-13 |
| Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS) (NCT06675864) | Novartis Pharmaceuticals | 2024-12-12 |
| To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise (NCT06647550) | Hyundai Pharm | 2024-12-12 |
| Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest (NCT06744361) | Christian Hassager | 2024-12-12 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME (NCT06708260) | EnnovaBio | 2024-12-12 |
| Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome (NCT06635629) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-12-12 |
| Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis (NCT06747858) | Arcturus Therapeutics, Inc. | 2024-12-12 |
| A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03. (NCT06780306) | BioTissue Holdings, Inc | 2024-12-12 |
| Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients (NCT05272826) | Canadian Myeloma Research Group | 2024-12-12 |
| Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell (NCT06575374) | M.D. Anderson Cancer Center | 2024-12-12 |
| Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial. (NCT06836505) | Sun Yat-Sen University Cancer Center | 2024-12-12 |
| Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer (NCT06463028) | Faeth Therapeutics | 2024-12-12 |
| A Phase 1/2 Trial of ADI-270 in ccRCC (NCT06480565) | Adicet Therapeutics | 2024-12-12 |
| A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma (NCT06669247) | Regeneron Pharmaceuticals | 2024-12-11 |
| Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1) (NCT06999902) | Praxis Precision Medicines | 2024-12-11 |
| A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS (NCT06715241) | ARCAGY/ GINECO GROUP | 2024-12-11 |
| Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia (NCT06516679) | Yonsei University | 2024-12-11 |
| Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2) (NCT06522360) | M.D. Anderson Cancer Center | 2024-12-11 |
| A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D (NCT06505928) | Shanghai HEP Pharmaceutical Co., Ltd. | 2024-12-11 |
| Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma (NCT06784648) | BioInvent International AB | 2024-12-11 |
| Belimumab in Autoimmune Hepatitis (NCT06381453) | University Health Network, Toronto | 2024-12-11 |
| A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis (NCT06636656) | Boehringer Ingelheim | 2024-12-11 |
| Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene (NCT06627179) | Laboratoires Thea | 2024-12-11 |
| Synergistic Effect of Non-invasive Brain and Spinal Cord Stimulation (NCT07334977) | Centre National de la Recherche Scientifique, France | 2024-12-11 |
| A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma (NCT06736613) | Memorial Sloan Kettering Cancer Center | 2024-12-11 |
| UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children (NCT05993767) | PENTA Foundation | 2024-12-11 |
| A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma (NCT06563505) | M.D. Anderson Cancer Center | 2024-12-11 |
| A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone (NCT06689163) | Jiangsu HengRui Medicine Co., Ltd. | 2024-12-11 |
| Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy (NCT06681324) | AstraZeneca | 2024-12-11 |
| A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) (NCT06630234) | Deciphera Pharmaceuticals, LLC | 2024-12-10 |
| CR-CHOP+X in Previously Untreated DEL (NCT06701357) | Ruijin Hospital | 2024-12-10 |
| A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion (NCT06820749) | Haisco Pharmaceutical Group Co., Ltd. | 2024-12-10 |
| A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. (NCT06566742) | M.D. Anderson Cancer Center | 2024-12-10 |
| A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (NCT06667453) | PepGen Inc | 2024-12-10 |
| Fluorescent Approach for Refined Endoscopic Marking With Clip Localization and Identification Procedure (NCT06714292) | Seoul National University Hospital | 2024-12-10 |
| Sleep to Reduce Incident Depression Effectively in Peripartum (NCT06430333) | Henry Ford Health System | 2024-12-10 |
| A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. (NCT06637631) | Sanofi | 2024-12-10 |
| Blinding and Adverse Effects of Ultrasonic Vagus Nerve Stimulation (U-VNS) (NCT07091812) | University of Nottingham | 2024-12-10 |
| Fexofenadine as Adjuvant Therapy in Parkinson Disease (NCT06785298) | Tanta University | 2024-12-10 |
| OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial (NCT06558214) | University of Florida | 2024-12-10 |
| Systemic Treatment Options for Generalized Lichen Planus (NCT06739551) | Sheikh Zayed Medical College | 2024-12-10 |
| Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer (NCT06730295) | Sun Yat-sen University | 2024-12-10 |
| A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia. (NCT06732895) | Ascendis Pharma A/S | 2024-12-10 |
| Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1 (NCT06718244) | Ruijin Hospital | 2024-12-10 |
| Novel Approaches to the Treatment of Hypothyroidism (NCT06731764) | UConn Health | 2024-12-10 |
| A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors (NCT06643754) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-12-10 |
| XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT06568562) | University of Utah | 2024-12-09 |
| A Dose-Response Safety Study of ENX-102 in Patients With GAD (NCT06653296) | Engrail Therapeutics INC | 2024-12-09 |
| Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone (NCT06384222) | Ivan de Kouchkovsky, MD | 2024-12-09 |
| A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity (NCT06717425) | Pfizer | 2024-12-09 |
| A Study of Cannabidiol in Young Adult Cannabis Users (NCT06569394) | University of Colorado, Denver | 2024-12-09 |
| Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial (NCT06636734) | Emory University | 2024-12-09 |
| A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. (NCT06588686) | Vicore Pharma AB | 2024-12-09 |
| Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities (NCT06662539) | Zealand Pharma | 2024-12-09 |
| A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC) (NCT06534983) | Hoffmann-La Roche | 2024-12-09 |
| Metformin IN Asthma for Overweight and Obese Individuals (MINA) (NCT06273072) | Johns Hopkins University | 2024-12-09 |
| Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older (NCT06727058) | Sanofi Pasteur, a Sanofi Company | 2024-12-09 |
| Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS) (NCT06042257) | Rachel G. Greenberg, MD, MB, MHS | 2024-12-09 |
| A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer (NCT06878625) | Tianjin Medical University Cancer Institute and Hospital | 2024-12-06 |
| A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) (NCT06667908) | Johnson & Johnson Enterprise Innovation Inc. | 2024-12-06 |
| Epcoritamab in Previously Treated WM (NCT06510491) | Gottfried von Keudell, MD PhD | 2024-12-06 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia (NCT06834932) | AstraZeneca | 2024-12-06 |
| Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma (NCT06540963) | Giselle Sholler | 2024-12-06 |
| Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors (NCT06728579) | Memorial Sloan Kettering Cancer Center | 2024-12-06 |
| A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis. (NCT06750276) | AstraZeneca | 2024-12-06 |
| Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer (NCT06381154) | Mayo Clinic | 2024-12-06 |
| A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa) (NCT06735755) | Beam Therapeutics Inc. | 2024-12-06 |
| BMB-101 in Absence Epilepsy and DEE (NCT06401538) | Bright Minds Biosciences Pty Ltd | 2024-12-05 |
| The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia (NCT06079931) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2024-12-05 |
| BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer (NCT06441890) | University of Illinois at Chicago | 2024-12-05 |
| A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults (NCT06742281) | CyanVac LLC | 2024-12-05 |
| A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn (NCT06651476) | Wake Forest University Health Sciences | 2024-12-05 |
| Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children (NCT07381530) | Dr. F. Köhler Chemie GmbH | 2024-12-05 |
| MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01) (NCT06534437) | Ryvu Therapeutics SA | 2024-12-05 |
| Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia (NCT07076706) | Beijing Dayspring Pharmaceutical Technology Co., Ltd | 2024-12-05 |
| Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension (NCT07064525) | Shin Poong Pharmaceutical Co. Ltd. | 2024-12-05 |
| Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity (NCT06617312) | University of California, Los Angeles | 2024-12-05 |
| Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes (NCT06712615) | ProGen. Co., Ltd. | 2024-12-05 |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer (NCT06607757) | GBG Forschungs GmbH | 2024-12-04 |
| Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC (NCT06693323) | University of California, Irvine | 2024-12-04 |
| Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients (NCT06701344) | Ruijin Hospital | 2024-12-04 |
| Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment (NCT06617858) | M.D. Anderson Cancer Center | 2024-12-04 |
| First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor. (NCT06603844) | Corbus Pharmaceuticals Inc. | 2024-12-04 |
| BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B (NCT06611436) | Be Biopharma | 2024-12-04 |
| Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis (NCT06475495) | Charite University, Berlin, Germany | 2024-12-04 |
| A Phase II Study to Evaluate NH102 for Depression (NCT06842992) | Jiangsu Nhwa Pharmaceutical Co., Ltd. | 2024-12-04 |
| A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus (NCT06700538) | Arrowhead Pharmaceuticals | 2024-12-04 |
| MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma (NCT06377540) | Masonic Cancer Center, University of Minnesota | 2024-12-04 |
| Cannabidiol and Cannabis Concentrate Users (NCT06575751) | University of Colorado, Denver | 2024-12-04 |
| Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection (NCT06706310) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-12-04 |